Oral administration of ferrulic acid was demonstrated to reduce AβO deposition in the cerebral region, and ferrulic acid diminished cognitive impairment in a mouse model, whereas antioxidant effects of ferrulic acid against AβO were attributed to the activation of Nrf2 via ERK1/2 pathway [83,84]. This evidence concerns the gene MAPK3 and Cognitive impairment.